KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) R&D In Process (2016 - 2023)

Johnson & Johnson's R&D In Process history spans 12 years, with the latest figure at $49.0 million for Q2 2023.

  • For Q2 2023, R&D In Process fell 91.97% year-over-year to $49.0 million; the TTM value through Apr 2023 reached $222.0 million, down 85.3%, while the annual FY2023 figure was $783.0 million, 13.0% down from the prior year.
  • R&D In Process for Q2 2023 was $49.0 million at Johnson & Johnson, down from $173.0 million in the prior quarter.
  • Across five years, R&D In Process topped out at $900.0 million in Q4 2021 and bottomed at $6.0 million in Q2 2020.
  • The 5-year median for R&D In Process is $155.5 million (2020), against an average of $350.4 million.
  • The largest annual shift saw R&D In Process skyrocketed 552.17% in 2021 before it plummeted 91.97% in 2023.
  • A 5-year view of R&D In Process shows it stood at $890.0 million in 2019, then tumbled by 84.49% to $138.0 million in 2020, then surged by 552.17% to $900.0 million in 2021, then tumbled by 32.22% to $610.0 million in 2022, then crashed by 91.97% to $49.0 million in 2023.
  • Per Business Quant, the three most recent readings for JNJ's R&D In Process are $49.0 million (Q2 2023), $173.0 million (Q1 2023), and $610.0 million (Q2 2022).